The year 2023 marked a period of significant progress for Esun Med LLC, a subsidiary of Ikh Uilsiin Ereld Group, as evidenced by the company's successful expansion of international relations and partnerships. Notably, Esun Med became the official distributor of the renowned U.S.-based company Illumina, enabling the supply of critical genetic sequencing equipment, reagents, and diagnostic kits to the Mongolian market.
Illumina Inc., a global leader in DNA sequencing technologies, launched the Global Health Access Initiative, aimed at advancing pathogen genomic sequencing for public health in low- and middle-income countries.
This initiative is designed to support public health needs by improving access to sequencing solutions. It was developed in alignment with input from end users, funders, and market-shaping organizations such as the non-profit FIND, and seeks to establish a tiered pricing model for sequencing products tailored to global health funding agencies. Furthermore, the program aims to tackle key challenges in international logistics and supply chain distribution.
